open access
Elevated serum irisin levels in boys with central precocious puberty independent of BMI
- Department of Paediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
open access
Abstract
Introduction: Central precocious puberty (CPP) is a prevalent endocrine disorder. Research has indicated that pubertal development is linked to nutritional metabolism. Irisin, a novel myokine/adipokine, has been identified as a potential predictor of CPP in girls. This study aims to examine the relationship between serum irisin levels and CPP in boys.
Material and methods: An enzyme-linked immunosorbent assay (ELISA) was used to measure serum irisin levels in 32 boys diagnosed with CPP and 33 prepubertal age-matched boys as normal controls (NC). To assess the impact of body mass index (BMI) on irisin levels, both the CPP and NC groups were divided into overweight/obese and normal-weight subgroups. Spearman correlation analysis was employed to assess the connection between irisin and clinical and biochemical parameters. Additionally, a receiver operating characteristic curve was utilised to determine the optimal threshold value for irisin.
Results: In the normal-weight subgroups, boys with CPP exhibited elevated irisin levels compared to controls, but not in the overweight/obese subgroups. The optimal cut-off value for irisin levels to predict CPP in the normal-weight groups was 93.09 ng/mL, yielding a sensitivity of 47.6% and a specificity of 100%. Furthermore, a positive correlation was noted between irisin levels and bone age (BA), bone age advancement (BA-CA), and BMI.
Conclusions: Serum irisin levels correlate with BMI and pubertal development. Given its limited sensitivity, irisin level can only be utilised as a supplementary rather than a standalone diagnostic indicator for CPP.
Abstract
Introduction: Central precocious puberty (CPP) is a prevalent endocrine disorder. Research has indicated that pubertal development is linked to nutritional metabolism. Irisin, a novel myokine/adipokine, has been identified as a potential predictor of CPP in girls. This study aims to examine the relationship between serum irisin levels and CPP in boys.
Material and methods: An enzyme-linked immunosorbent assay (ELISA) was used to measure serum irisin levels in 32 boys diagnosed with CPP and 33 prepubertal age-matched boys as normal controls (NC). To assess the impact of body mass index (BMI) on irisin levels, both the CPP and NC groups were divided into overweight/obese and normal-weight subgroups. Spearman correlation analysis was employed to assess the connection between irisin and clinical and biochemical parameters. Additionally, a receiver operating characteristic curve was utilised to determine the optimal threshold value for irisin.
Results: In the normal-weight subgroups, boys with CPP exhibited elevated irisin levels compared to controls, but not in the overweight/obese subgroups. The optimal cut-off value for irisin levels to predict CPP in the normal-weight groups was 93.09 ng/mL, yielding a sensitivity of 47.6% and a specificity of 100%. Furthermore, a positive correlation was noted between irisin levels and bone age (BA), bone age advancement (BA-CA), and BMI.
Conclusions: Serum irisin levels correlate with BMI and pubertal development. Given its limited sensitivity, irisin level can only be utilised as a supplementary rather than a standalone diagnostic indicator for CPP.
Keywords
irisin; central precocious puberty; BMI; boys
Title
Elevated serum irisin levels in boys with central precocious puberty independent of BMI
Journal
Issue
Article type
Original paper
Pages
216-221
Published online
2024-04-02
Page views
116
Article views/downloads
35
DOI
Pubmed
Bibliographic record
Endokrynol Pol 2024;75(2):216-221.
Keywords
irisin
central precocious puberty
BMI
boys
Authors
Dan Zeng
Yanfei Chen
Tao Xie
Wei Qin
Qi Meng
Dan Lan
- Partsch CJ, Sippell WG. Pathogenesis and epidemiology of precocious puberty. Effects of exogenous oestrogens. Hum Reprod Update. 2001; 7(3): 292–302.
- Kim SH, Huh K, Won S, et al. A Significant Increase in the Incidence of Central Precocious Puberty among Korean Girls from 2004 to 2010. PLoS One. 2015; 10(11): e0141844.
- Kim YeJ, Kwon A, Jung MoK, et al. Incidence and Prevalence of Central Precocious Puberty in Korea: An Epidemiologic Study Based on a National Database. J Pediatr. 2019; 208: 221–228.
- Bräuner EV, Busch AS, Eckert-Lind C, et al. Trends in the Incidence of Central Precocious Puberty and Normal Variant Puberty Among Children in Denmark, 1998 to 2017. JAMA Netw Open. 2020; 3(10): e2015665.
- Kang S, Park MiJ, Kim JM, et al. Ongoing increasing trends in central precocious puberty incidence among Korean boys and girls from 2008 to 2020. PLoS One. 2023; 18(3): e0283510.
- Pereira A, Busch AS, Solares F, et al. Total and Central Adiposity Are Associated With Age at Gonadarche and Incidence of Precocious Gonadarche in Boys. J Clin Endocrinol Metab. 2021; 106(5): 1352–1361.
- Aghaee S, Deardorff J, Quesenberry C, et al. Associations Between Childhood Obesity and Pubertal Timing Stratified by Sex and Race/Ethnicity. Am J Epidemiol. 2022; 191(12): 2026–2036.
- Liang X, Huang Ke, Dong G, et al. Current Pubertal Development in Chinese Children and the Impact of Overnutrition, Lifestyle, and Perinatal Factors. J Clin Endocrinol Metab. 2023; 108(9): 2282–2289.
- Shi Li, Jiang Z, Zhang Li. Childhood obesity and central precocious puberty. Front Endocrinol (Lausanne). 2022; 13: 1056871.
- Roca-Rivada A, Castelao C, Senin LL, et al. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One. 2013; 8(4): e60563.
- Maak S, Norheim F, Drevon CA, et al. Progress and Challenges in the Biology of FNDC5 and Irisin. Endocr Rev. 2021; 42(4): 436–456.
- Aydin S, Kuloglu T, Aydin S, et al. A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues. Peptides. 2014; 61: 130–136.
- Gençer Tarakçı B, Girgin A, Timurkaan S, et al. Immunohistochemical localization of irisin in skin, eye, and thyroid and pineal glands of the crested porcupine (Hystrix cristata). Biotech Histochem. 2016; 91(6): 423–427.
- Gür FM, Timurkaan S, Yalcin MH, et al. Immunohistochemical localization of irisin in mole rats (Spalax leucodon). Biotech Histochem. 2017; 92(4): 245–251.
- Gür FM, Timurkaan S, Gençer Tarakçi B, et al. Identification of immunohistochemical localization of irisin in the dwarf hamster (Phodopus roborovskii) tissues. Anat Histol Embryol. 2018; 47(2): 174–179.
- Wahab F, Khan IU, Polo IR, et al. Irisin in the primate hypothalamus and its effect on GnRH in vitro. J Endocrinol. 2019; 241(3): 175–187.
- Wahab F, Drummer C, Mätz-Rensing K, et al. Irisin is expressed by undifferentiated spermatogonia and modulates gene expression in organotypic primate testis cultures. Mol Cell Endocrinol. 2020; 504: 110670.
- Wrann CD, White JP, Salogiannnis J, et al. Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway. Cell Metab. 2013; 18(5): 649–659.
- Poretsky L, Islam J, Avtanski D, et al. Reproductive effects of irisin: Initial in vitro studies. Reprod Biol. 2017; 17(3): 285–288.
- Jiang Q, Zhang Q, Lian A, et al. Irisin stimulates gonadotropins gene expression in tilapia (Oreochromis niloticus) pituitary cells. Anim Reprod Sci. 2017; 185: 140–147.
- Kutlu E, Ozgen LT, Bulut H, et al. Investigation of irisin's role in pubertal onset physiology in female rats. Peptides. 2023; 163: 170976.
- Ulker N, Yardimci A, Kaya Tektemur N, et al. Irisin may have a role in pubertal development and regulation of reproductive function in rats. Reproduction. 2020; 160(2): 281–292.
- Reinehr T, Elfers C, Lass N, et al. Irisin and its relation to insulin resistance and puberty in obese children: a longitudinal analysis. J Clin Endocrinol Metab. 2015; 100(5): 2123–2130.
- Kutlu E, Özgen İT, Bulut H, et al. Serum Irisin Levels in Central Precocious Puberty and Its Variants. J Clin Endocrinol Metab. 2021; 106(1): e247–e254.
- Chen Y, Li M, Liao B, et al. Serum irisin levels increase in girls with central precocious puberty not dependent on BMI: a pilot study. Endocr Connect. 2022; 11(4).
- Cheuiche AV, da Silveira LG, de Paula LC, et al. Diagnosis and management of precocious sexual maturation: an updated review. Eur J Pediatr. 2021; 180(10): 3073–3087.
- Li H, Ji CY, Zong XN, et al. Body mass index growth curves for Chinese children and adolescents aged 0 to 18 years][J]. Zhonghua Er Ke Za Zhi, 2009, 47(7):493-498. Zhonghua Er Ke Za Zhi. 2009; 47(7): 493–498.
- Palacios-González B, Vadillo-Ortega F, Polo-Oteyza E, et al. Irisin levels before and after physical activity among school-age children with different BMI: a direct relation with leptin. Obesity (Silver Spring). 2015; 23(4): 729–732.
- Çatlı G, Küme T, Tuhan HÜ, et al. Relation of serum irisin level with metabolic and antropometric parameters in obese children. J Diabetes Complications. 2016; 30(8): 1560–1565.
- Jang HB, Kim HJ, Kang JH, et al. Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents. Metabolism. 2017; 73: 100–108.
- Binay Ç, Paketçi C, Güzel S, et al. Serum Irisin and Oxytocin Levels as Predictors of Metabolic Parameters in Obese Children. J Clin Res Pediatr Endocrinol. 2017; 9(2): 124–131.
- Jia J, Yu F, Wei WP, et al. Relationship between circulating irisin levels and overweight/obesity: A meta-analysis. World J Clin Cases. 2019; 7(12): 1444–1455.
- Barnett SM, Jackson AH, Rosen BA, et al. Nephrolithiasis and Nephrocalcinosis From Topiramate Therapy in Children With Epilepsy. Kidney Int Rep. 2018; 3(3): 684–690.
- Taş D, Akman Öden A, Akgül S, et al. The Effect of Pubertal Stage on the Concentrations of the Novel Adipomyokine, Irisin, in Male Adolescents. J Clin Res Pediatr Endocrinol. 2020; 12(2): 168–174.
- He J, Kang Y, Zheng L. Correlation of serum levels of LH, IGF-1 and leptin in girls with the development of idiopathic central precocious puberty. Minerva Pediatr (Torino). 2023; 75(3): 381–386.
- Wahab F, Shahab M, Behr R. Hypothesis: Irisin is a metabolic trigger for the activation of the neurohormonal axis governing puberty onset. Med Hypotheses. 2016; 95: 1–4.